Castaman G - Search Results

1

Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease.

Castaman G, Coppola A, Zanon E, Boeri E, Musso M, Siragusa S, Federici AB, Mancuso G, Barillari G, Biasoli C, Feola G, Franchini M, Moratelli S, Gamba G, Schinco P, Valdrè L, Dragani A, Mazzucconi G, Tagliaferri A, Morfini M. Castaman G, et al. Haemophilia. 2013 Jan;19(1):82-8. doi: 10.1111/hae.12005. Epub 2012 Sep 7. Haemophilia. 2013. PMID: 22957493

2

Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate.

Castaman G, Tosetto A, Rodeghiero F. Castaman G, et al. Am J Hematol. 1992 Oct;41(2):132-6. doi: 10.1002/ajh.2830410212. Am J Hematol. 1992. PMID: 1415174

3

In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.

d'Alessio PA, Castaman G, Rodeghiero F, de Boer HC, Federici AB, Mannucci PM, de Groot PG, Sixma JJ, Zwaginga JJ. d'Alessio PA, et al. Among authors: castaman g. Thromb Res. 1992 Jan 15;65(2):221-8. doi: 10.1016/0049-3848(92)90242-3. Thromb Res. 1992. PMID: 1579897

4

The bleeding time in normal subjects is mainly determined by platelet von Willebrand factor and is independent from blood group.

Rodeghiero F, Castaman G, Ruggeri M, Tosetto A. Rodeghiero F, et al. Among authors: castaman g. Thromb Res. 1992 Mar 1;65(4-5):605-15. doi: 10.1016/0049-3848(92)90210-2. Thromb Res. 1992. PMID: 1615498

5

A new variant of von Willebrand disease (type II I) with a normal degree of proteolytic cleavage of von Willebrand factor.

Castaman G, Rodeghiero F, Lattuada A, Mannucci PM. Castaman G, et al. Thromb Res. 1992 Feb 1;65(3):343-51. doi: 10.1016/0049-3848(92)90165-7. Thromb Res. 1992. PMID: 1631800

6

Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease.

Rodeghiero F, Castaman G, Meyer D, Mannucci PM. Rodeghiero F, et al. Among authors: castaman g. Vox Sang. 1992;62(4):193-9. doi: 10.1111/j.1423-0410.1992.tb01198.x. Vox Sang. 1992. PMID: 1642002 Review.

7

Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease.

Rodeghiero F, Castaman G, Mannucci PM. Rodeghiero F, et al. Among authors: castaman g. Blood Rev. 1991 Sep;5(3):155-61. doi: 10.1016/0268-960x(91)90032-8. Blood Rev. 1991. PMID: 1777748 Review.

8

von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease--results based on an epidemiological investigation.

Rodeghiero F, Castaman G, Tosetto A. Rodeghiero F, et al. Among authors: castaman g. Thromb Haemost. 1990 Nov 30;64(3):349-52. Thromb Haemost. 1990. PMID: 2096485

9

Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.

d'Alessio P, Zwaginga JJ, de Boer HC, Federici AB, Rodeghiero F, Castaman G, Mariani G, Mannucci PM, de Groot PG, Sixma JJ. d'Alessio P, et al. Among authors: castaman g. Thromb Haemost. 1990 Oct 22;64(2):227-31. Thromb Haemost. 1990. PMID: 2125373

10

The von Willebrand factor.

Rodeghiero F, Castaman G. Rodeghiero F, et al. Among authors: castaman g. Ric Clin Lab. 1990 Apr-Jun;20(2):143-53. doi: 10.1007/BF02877561. Ric Clin Lab. 1990. PMID: 2196663 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters